Last reviewed · How we verify

NCT03163823: iPad

CTSI-iPad for Vented Patient Communication

Completed NA Last updated 20 May 2021
What this trial tests

NA trial testing Proloquo2Go in Respiratory Failure in 21 participants. Completed in 21 September 2020.

Timeline
23 February 2017
Primary endpoint
21 September 2020
21 September 2020

Quick facts

Lead sponsorMedical College of Wisconsin
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposesupportive care
Enrollment21
Start date23 February 2017
Primary completion21 September 2020
Estimated completion21 September 2020
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Medical College of Wisconsin

Who can join

18 and older, any sex, with Respiratory Failure. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will enroll 75 mechanically vented adults in the ICU to compare self-reported ease of communication, patient satisfaction, and patient anxiety and frustration levels between a group using a communication application on an iPad and a group using standard methods of communication while mechanically vented.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Respiratory Failure

Currently open trials in the same condition.

Other Medical College of Wisconsin trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03163823.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing